Lunaphore raises CHF 23 million
06.02.2020
Share this article
Lunaphore closes its Series C funding
On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the completion of its Series C funding of CHF 23 million, adding to its existing capital of CHF 11.3 million.
The startup provides high speed qualitative automated tools which use immunohistochemistry to deliver precise diagnostics. Lunaphore aims to use the newly acquired investment in the development of new products and its US market activities.